2021年6月28日 · A group led by Swathi Sangli, MBBS, Allegheny Health Network, Pittsburgh, Pennsylvania, describe what they say appears to be the development of vaccine-induced thrombosis with thrombocytopenia ...

2025年2月10日 · They included participants who received mRNA vaccines (BNT162b2 or mRNA-1273) or adenoviral vector vaccines (Ad26.COV2.S) from January 2022 to December 2023. ... over 12 months was significantly ...

2025年1月22日 · TOPLINE: A population-based congenital cytomegalovirus (cCMV) screening program in Ontario successfully screened 551,034 (97.4%) newborns, with 689 (0.13%) testing positive.

2024年11月5日 · A new vaccine using mRNA technology protected against first-time and relapsing Clostridioides difficile infection in animal models, according to a press release from the Perelman School of ...

2024年1月17日 · Treatment with mRNA-4157 (V940) in combination with pembrolizumab led to a clinically meaningful improvement in recurrence-free survival, reducing the risk for recurrence or death by 49%, compared ...

2024年11月21日 · From Medscape Gastroenterology Coverage from the The Liver Meeting 2024: American Association for the Study of Liver Diseases (AASLD) November 15 - 19, 2024; San Diego, California

2025年3月3日 · The mRNA vaccine technology can be modified more quickly to respond to mutations than traditional vaccine approaches, he added. “Based on our experience with COVID-19, assuming all necessary ...

2023 - 53 (12) Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. December 01, 2023 [ MEDLINE Abstract] COVID-19 illness: Different comorbidities may require different immunological ...

2024年5月2日 · An mRNA vaccine with coding sequences for the pre-fusion protein of RSV is in phase 3 trials for approval for vaccination in patients aged 60 years and older. It shows high effectiveness even in ...

2025年2月24日 · Drugs COVID-19 vaccine, mRNA-Moderna; Diseases & Conditions COVID-19 Variants; Related Conditions & Procedures. COVID-19 Variants; COVID-19 Pulmonary Management; COVID-19 Reinfections;